Eli Lilly has scrapped plans to develop a potential diabetes treatment due to unresolved questions about changes in liver fat that cropped up during late-stage testing of the drug. Eli Lilly ends development of insulin peglispro Eli Lilly has scrapped plans to develop a potential diabetes treatment due to unresolved questions about changes in liver fat that cropped up during late-stage testing of the drug.